Approximately half of patients with ST-segment elevation acute myocardial infarction (STEMI) have multivessel coronary artery disease. Evidence from randomized controlled trials (RCT) comparing multivessel to culprit-only percutaneous coronary intervention (PCI)… Click to show full abstract
Approximately half of patients with ST-segment elevation acute myocardial infarction (STEMI) have multivessel coronary artery disease. Evidence from randomized controlled trials (RCT) comparing multivessel to culprit-only percutaneous coronary intervention (PCI) in STEMI has been controversial. We
               
Click one of the above tabs to view related content.